CS logo
small CS logo
University of Mannheim

Mannheim, Germany
Hochschule in Mannheim, Baden-Württemberg

About University of Mannheim


Die Universität Mannheim ist eine Universität im baden-württembergischen Mannheim und zählt – 1907 als städtische Handels-Hochschule gegründet und seit 1967 Universität – zu den jüngeren Universitäten Deutschlands.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
BiO2 Medical
1
Bristol-Myers Squibb
1
Harbinger Medical, Inc.
1
Respicardia, Inc.
1
TVA Medical Inc.
1
Universitätsklinikum Hamburg-Eppendorf
1
Total Rows: 6

Clinical Trials at University of Mannheim


During the past decade, University of Mannheim conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years2200Started TrialsCompleted Trails20160123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma
2004-09-01
2009-10-01
Completed
1,783
Prospective Study to Identify Patients at Risk of Dangerous Ventricular Arrhythmias
2003-09-01
2009-10-01
Unknown status
320
Identification of the Pericardiophrenic Vein During Cardiac Device Implant Procedures to Prevent Extracardiac Stimulation
2007-12-01
2010-10-01
Completed
120
Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer
2014-04-01
2024-04-01
Active, not recruiting
789
everlinQ endoAVF Post Market Study
2016-09-20
2019-08-01
Terminated
100
Angel® Catheter Post Market Registry
2016-07-01
2018-07-01
Unknown status
2,000

Rows per page:

1–6 of 6

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "University of Mannheim" #1 sponsor was "BiO2 Medical" with 1 trials, followed by "Bristol-Myers Squibb" with 1 trials sponsored, "Harbinger Medical, Inc." with 1 trials sponsored, "Respicardia, Inc." with 1 trials sponsored and "TVA Medical Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Mannheim" #1 collaborator was "Australasian Gastro-Intestinal Trials Group" with 1 trials as a collaborator, "Cancer Research UK" with 1 trials as a collaborator, "Deutsche Krebshilfe e.V., Bonn (Germany)" with 1 trials as a collaborator and "Dutch Cancer Society" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.
Created with Highcharts 11.1.0Top Leading SponsorsBiO2 Medical: 1BiO2 Medical: 1Bristol-Myers Squibb: 1Bristol-Myers Squibb: 1Harbinger Medical, Inc.: 1Harbinger Medical, Inc.: 1Respicardia, Inc.: 1Respicardia, Inc.: 1TVA Medical Inc.: 1TVA Medical Inc.: 1UniversitätsklinikumHamburg-Eppendorf: 1UniversitätsklinikumHamburg-Eppendorf: 1

Created with Highcharts 11.1.0Top CollaboratorsAustralasian Gastro-Intestinal Trials Group:1Australasian Gastro-Intestinal Trials Group:1Cancer Research UK: 1Cancer Research UK: 1Deutsche Krebshilfee.V., Bonn (Germany):1Deutsche Krebshilfee.V., Bonn (Germany):1Dutch Cancer Society: 1Dutch Cancer Society: 1

Clinical Trials Conditions at University of Mannheim


According to Clinical.Site data, the most researched conditions in "University of Mannheim" are "Catheter Thrombosis" (1 trials), "Catheter-related Bloodstream Infection (CRBSI) Nos" (1 trials), "Cholangiocarcinoma" (1 trials), "Chronic Kidney Disease" (1 trials) and "Deep Vein Thrombosis" (1 trials). Many other conditions were trialed in "University of Mannheim" in a lesser frequency.

Clinical Trials Intervention Types at University of Mannheim


Most popular intervention types in "University of Mannheim" are "Device" (2 trials), "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Angel® Catheter" (1 trials), "Capecitabine" (1 trials), "Cisplatin" (1 trials), "Gemcitabine" (1 trials) and "MDX-010 (anti-CTLA4) monoclonal antibody" (1 trials). Other intervention names were less common.

Clinical Trials Genders at University of Mannheim


The vast majority of trials in "University of Mannheim" are 6 trials for "All" genders.

Clinical Trials Status at University of Mannheim


Currently, there are NaN active trials in "University of Mannheim". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in University of Mannheim, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in University of Mannheim, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 2Phase 3: 2Not Applicable: 1Not Applicable: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 2Completed: 2Unknown status: 2Unknown status: 2Active, not recruiting: 1Active, not recruiting: 1Terminated: 1Terminated: 1